Current event;

Astellas pharmaceutical recieved half the profits from enzalutamide drug ( formally Medivation/Astella pharma which Pfizer bought for $14 Billion US ) Could Astellas be our 2016 regional deal that Don referred to (Japenese Suitor ?) How would this look in light of recent AGM's cancellations ...

Since we know Pfizer is a Big player in oncology, with its latest purchase in prostrate cancer drug developer Medivation, I started imagining Astella Pharmaceutical sitting in money looking for a new drug/drugs, spying Zenith Epigenic Ltd and scafold of molecules as new interest . Maybe while exploring Zenith they see interest in parent company Resverlogix and its vast chest of molecules available . I'm of the camp "my view " that Astella pharma buys rights and marketing for Japan in both companies/ drug development for 68 million + Royalties and relinguish Dart's strangle hold (citi loan)

If drugs become proven and succeed Pfizer buys both companies lock (stock) and barrel !

This kind of dreaming takes time to unfold and Oct 5 is just to damn close !

Stock (just rambling) as we don't know why our companies do what they do ......